Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norma Bloy

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
Oncoimmunology|July 9, 2015
Trial watch: Naked and vectored DNA-based anticancer vaccinesNorma Bloy, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 10, 2015
Trial Watch: Adoptive cell transfer for oncological indicationsFernando Aranda, Aitziber Buqué, Norma Bloy, et al.
Oncoimmunology|May 6, 2015
Trial watch: Dendritic cell-based anticancer therapyNorma Bloy, Jonathan Pol, Fernando Aranda, et al.
Oncoimmunology|July 3, 2015
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Nature Immunology|August 5, 2020
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagyTakahiro Yamazaki, Alexander Kirchmair, Ai Sato, et al.
Oncoimmunology|November 18, 2016
The ratio of CD8<sup>+</sup>/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma <i>in situ</i>Michaela Semeraro, Julien Adam, Gautier Stoll, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
Oncoimmunology|July 9, 2015
Trial watch: Naked and vectored DNA-based anticancer vaccinesNorma Bloy, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 10, 2015
Trial Watch: Adoptive cell transfer for oncological indicationsFernando Aranda, Aitziber Buqué, Norma Bloy, et al.
Oncoimmunology|May 6, 2015
Trial watch: Dendritic cell-based anticancer therapyNorma Bloy, Jonathan Pol, Fernando Aranda, et al.
Oncoimmunology|July 3, 2015
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Nature Immunology|August 5, 2020
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagyTakahiro Yamazaki, Alexander Kirchmair, Ai Sato, et al.
Oncoimmunology|November 18, 2016
The ratio of CD8<sup>+</sup>/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma <i>in situ</i>Michaela Semeraro, Julien Adam, Gautier Stoll, et al.
Pageof 6